Investors include Casa Verde Capital, Thrive Capital, Tiger Global Management, Gron Ventures, Thirty Five Ventures and Howard Schultz. The company provides dispensaries the technology needed to allow for “easy access to cannabis for everyone.” Dutchie – Total Funding: $253,000,000ĭutchie is an Oregon-based cannabis delivery platform connecting dispensaries with consumers in the U.S. Investors include Nosara Capital, Founders Fund, Thrive Capital, Lerer Hippeau, Phyto Partners and Snoop Dogg’s Casa Verde Capital. The company offers a wholesale marketplace for cannabis retailers, brands, and distributors, as well as financial, data and advertising services. LeafLink is a cannabis B2B platform founded in 2016 with the goal of streamlining the cannabis supply chain. CERE CERAF, a SPAC in the cannabis space. In February, the company announced intentions of going public through a merger with Ceres Acquisition Corp. Investors include Poseidon Asset Management and Patrón Spirits’ Edward Brown. The company operates approximately 50 locations nationwide, including 42 retail stores, cultivation and manufacturing sites. Parallel is a vertically integrated, multi-state cannabis company with operations in Pennsylvania, Texas, Illinois, Florida and Nevada. Investors include Fidelity, Poseidon Asset Management, Tiger Global Management, Tao Capital Partners and Sands Hill Angels. PAX devices are sold in select states across the US, Canada and retail stores throughout select European markets. The company produces several top-tier vaping products for cannabis consumers. Pax Labs is a manufacturer of electronic vaporizers with an eye on the premium consumer market. Vertical Companies – Total Funding: $58,000,000.

Holistic Industries – Total Funding: $156,095,000.Privateer Holdings – Total Funding: $228,000,000.Releasing shares in a public exchange can sometimes become an operational nightmare, requiring entire teams to deal with filings and public disclosures.Īdditionally, selling part of a company to the public can dilute shareholder value and limit the management team's freedom to make decisions.įor these reasons, many companies decide to remain private if they can continue to secure capital through existing revenue or private financing.īelow is a list of the top 15 privately-held cannabis, CBD and hemp companies by total funding, according to Crunchbase data. While going public is an effective method for raising capital, it’s not necessarily the ultimate goal for every private company or startup. However, a substantial number of well-known privately-owned companies in the cannabis space continue to raise capital through private equity funding and have not listed their shares in public stock exchanges. in Microbiology from the University of Texas at Arlington.For many people, investing in cannabis has become tantamount to buying shares of publicly-listed companies like Canopy Growth CGC, Curaleaf CURLF or Tilray TLRY. in Molecular and Cellular Biology from the University of Texas Southwestern Medical Center at Dallas, and a B.S. from the Georgetown University Law Center, a M.S. Paul also led personalized medicine policy at the Biotechnology Innovation Organization after practicing in two large, international law firms as a legal associate and regulatory science advisor in the areas of FDA and reimbursement law. Prior to this experience, Paul led reimbursement and regulatory activities at the American Laboratory Clinical Laboratory Association American Clinical Laboratory Association and served as that organization’s staff representative to the Pathology Coding Caucus, an advisory board to the AMA CPT Editorial Panel. A molecular biologist and lawyer by training, he most recently led health policy and reimbursement at Roche Diagnostics. Paul brings nearly two decades of experience advising and leading life sciences companies on issues related to reimbursement, regulatory and government relations.

Dia and co crunchbase